Literature DB >> 15132827

Upregulation of heparin-binding growth-associated molecule after spinal cord injury in adult rats.

Yan-Ting Wang1, Shu Han, Kai-Hua Zhang, Yu Jin, Xiao-Ming Xu, Pei-Hua Lu.   

Abstract

AIM: To investigate whether traumatic spinal cord injury (SCI) induces changes of gene expression of heparin-binding growth-associated molecule (HB-GAM).
METHODS: In a spinal cord transection model, HB-GAM expression and cellular localization were examined using Northern blot, RT-PCR, immunohistochemistry and immunofluorescence double-labeling methods.
RESULTS: HB-GAM mRNA was significantly upregulated in spinal cord tissues rostral and caudal to the injury at 7 d after SCI. HB-GAM gene expression was markedly increased at 3 d, peaked at 7 d, and declined to the baseline level at 28 d post-injury. During its peak expression, HB-GAM was co-localized in astrocytes, oligodendrocytes, and neurons in spinal cord tissues within 7 mm from the site of spinal transection.
CONCLUSION: SCI induces HB-GAM expression at both mRNA and protein levels in areas close to the injury. Both neurons and glial cells expressed HB-GAM implying that HB-GAM played a role in the process of injury and/or repair following SCI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15132827

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  3 in total

Review 1.  Pleiotrophin and peripheral nerve injury.

Authors:  Li Jin; Chen Jianghai; Liu Juan; Kang Hao
Journal:  Neurosurg Rev       Date:  2009-05-08       Impact factor: 3.042

Review 2.  Cellular therapies for treating pain associated with spinal cord injury.

Authors:  Lawrence Leung
Journal:  J Transl Med       Date:  2012-03-06       Impact factor: 5.531

3.  Heparin-Binding Growth-Associated Molecule (Pleiotrophin) Affects Sensory Signaling and Selected Motor Functions in Mouse Model of Anatomically Incomplete Cervical Spinal Cord Injury.

Authors:  Natalia Kulesskaya; Dmitry Molotkov; Sonny Sliepen; Ekaterina Mugantseva; Arturo Garcia Horsman; Mikhail Paveliev; Heikki Rauvala
Journal:  Front Neurol       Date:  2021-12-06       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.